Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Pavel P. Rumyantsev"'
Autor:
Pavel O. Rumyantsev, Andrey G. Baidak
Publikováno v:
Digital Diagnostics, Vol 3, Iss 1, Pp 86-93 (2022)
High achievements in personalized evidence-based medicine and oncology, particularly in developed countries, are associated with the successful development of clinical carceral registries of patients (SEER, NCDB, etc.), which are multimodal data bank
Externí odkaz:
https://doaj.org/article/77e13ee74de24b76b2fbf21d26517800
Autor:
Konstantin Y. Slashchuk, Mikhail V. Degtyarev, Pavel O. Rumyantsev, Olga Y. Rebrova, Alina R. Elfimova, Liliya S. Selivanova, Nataliya G. Mokrysheva
Publikováno v:
Современная онкология, Vol 24, Iss 1, Pp 97-105 (2022)
Background: Primary hyperparathyroidism (PHPT) is the third most common endocrine disease, after diabetes mellitus and thyroid gland disorders. Surgical removal of the hyperfunctioning parathyroid glands is the only radical treatment. Various methods
Externí odkaz:
https://doaj.org/article/9ed8f2a2fc2e49949ccf4e7f38313a6c
Autor:
Pavel O. Rumyantsev
Publikováno v:
Digital Diagnostics, Vol 2, Iss 4, Pp 488-497 (2022)
Brachytherapy is successfully used in the treatment of malignant neoplasms in males and females and rare cases in children, as an independent method (with localized prostate cancer) or adjuvant with remote focal radiation therapy (with cancer of the
Externí odkaz:
https://doaj.org/article/5a76b18758a14f50bc045d9e959b38aa
Autor:
Pavel O. Rumyantsev
Publikováno v:
Digital Diagnostics, Vol 2, Iss 1, Pp 83-89 (2021)
Radionuclide therapy is a radionuclide therapy based on molecular imaging using various radiopharmaceuticals (RP), allowing in vivo visualization (SPECT, PET) and selectively affecting pathological metabolic processes caused by a tumor. Using the par
Externí odkaz:
https://doaj.org/article/64122c8f41cc4f938c31198465e055bf
Autor:
Konstantin Y. Slashchuk, Michail V. Degtyarev, Pavel O. Rumyantsev, Ekaterina A. Troshina, Galina A. Melnichenko
Publikováno v:
Эндокринная хирургия, Vol 13, Iss 4, Pp 153-174 (2020)
Primary hyperparathyroidism (PHPT) is a common endocrine disease that occurs with multiple profiles in which no classical manifestation. Diagnosis revolves around routine measurement of serum calcium and parathyroid hormone more than in half cases. T
Externí odkaz:
https://doaj.org/article/73d51c906fb2412fae7343f0d4a37ba6
Autor:
Tatiana A. Grebennikova, Diliara Sh. Umiarova, Konstantin Y. Slashchuk, Mikhail V. Degtyarev, Svetlana S. Rodionova, Pavel O. Rumyantsev, Zhanna E. Belaya
Publikováno v:
Остеопороз и остеопатии, Vol 21, Iss 4, Pp 24-28 (2019)
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome usually caused by small-sized tumors. Tumors secrete fibroblast growth factor 23 (FGF23), which has a phosphaturic effect. The clinical signs of TIO are non-specific, and include fati
Externí odkaz:
https://doaj.org/article/130c804ea7fa4d28b5f9faa4074fc4c9
Autor:
Ivan I. Dedov, Pavel O. Rumyantsev, Ksenia S. Nizhegorodova, Konstantin Y. Slashchuk, Valentina S. Yasyuchenya, Marina S. Sheremeta, Michail V. Degtyarev, Larisa V. Nikankina, Galina A. Melnichenko
Publikováno v:
Эндокринная хирургия, Vol 12, Iss 3, Pp 128-139 (2018)
Background. Traditional endogenous stimulation of thyroid-stimulating hormone (TSH) by means of long-term withdrawal of thyroid hormones for radioiodine diagnostics and radioiodine therapy causes severe hypothyroidism, which worsens patients general
Externí odkaz:
https://doaj.org/article/d495efcbc7b540569a2285579f46674d
Autor:
Natalia G. Mokrysheva, Anna K. Eremkina, Konstantin U. Slashchuk, Alexey I. Bespalov, Iya А. Voronkova, Pavel O. Rumyantsev, Mikhail V. Degtyarev, Nikolay S. Kuznetzov, Nonna V. Latkina
Publikováno v:
Эндокринная хирургия, Vol 12, Iss 1, Pp 55-63 (2018)
Primary hyperparathyroidism is common clinical endocrine disorder with a prevalence between 12%. Solitary parathyroid adenomas account from 80 to 85% of cases of PHPT, hyperplasia and multiple adenomas is up to 15%, parathyroid carcinoma is a very ra
Externí odkaz:
https://doaj.org/article/a47c203bdfc742f88818333e2bc5f54d
Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
Autor:
Pavel O. Rumyantsev, Diana R. Yazykova, Konstantin Y. Slashchuk, Mikhail V. Degtyarev, Valentina S. Yasyuchenya, Sergey S. Serzhenko, Marina S. Sheremeta, Ivan I. Dedov
Publikováno v:
Эндокринная хирургия, Vol 12, Iss 1, Pp 19-39 (2018)
Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumours, up to 40% of which occur in the setting of a hereditary syndrome. The incidence is 2 to 8 per million persons per year. The peak incidence occurs in
Externí odkaz:
https://doaj.org/article/dbc40204cc8c4d5e998df4229c16da6c
Autor:
Vladimir G. Polyakov, Ruslan V. Shishkov, Aleksei A. Ilyin, Severskaya N. Viktorovna, Natalia V. Ivanova, Roman I. Pimenov, Valentina M. Kozlova, Faina A. Amosenko, Ludmila N. Lubchenko, Tatyiana P. Kazubskaya, Alentina I. Pavlovskaya, Oleg P. Bleznukov, Natalia A. Koshechkina, Elena V. Mikhaylova, Tamara R. Panferova, Irina I. Matveeva, Irina N. Serebryakova, Svetlana N. Mikhaylova, Victor S. Medvedev, Pavel A. Isaev, Pavel O. Rumyantsev, Alexandr U. Abrosimov, Natalia U. Kalinchenko
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 12, Iss 1, Pp 22-33 (2016)
Genetically caused medullary thyroid cancer (MTC) is associated with unfavorable survival prognosis, so it makes necessary to develop new diagnostic techniques to reveal pre-clinical stage of disease as well as to introduce into clinical practice the
Externí odkaz:
https://doaj.org/article/90e86b64155241c3acf2c2b1131c150e